SOLESENCE, INC.

Solésence, Inc. is a leading innovator in scientifically driven healthcare solutions across beauty, health, and wellness categories. The company protects skin from environmental aggressors and enhances the aesthetic appeal of health-enhancing products. On March 7, 2025, Nanophase Technologies Corporation announced its rebranding as Solésence, Inc., and legally changed its name on March 10, 2025, with a certificate of correction filed on June 3, 2025. Solésence, along with its wholly owned subsidiary, Solésence, LLC, focuses primarily on skin health through its Consumer Products and Active Pharmaceutical Ingredients (APIs). Additional revenue is generated from other legacy advanced materials applications. The company was incorporated in Illinois on November 25, 1989, and became a Delaware corporation in November 1997. Its common stock trades on NASDAQ under the symbol SLSN. Solésence has development and testing laboratories, and manufacturing capability in two locations in the Chicago, Illinois area. Leveraging a platform of integrated patented and proprietary technologies, Solésence creates products with unique performance to enhance end-consumers' health and well-being. The company offers comprehensive production, starting with engineered materials, formulation development, and finished product development, through commercial manufacturing and packaging capabilities. Its expertise in materials engineering allows for effective coating and dispersion of materials on a nano and "non-nano" scale for use in various skin health markets, including sunscreens as APIs. In addition to APIs, Solésence produces finished skin care, sun care, and color cosmetics products through the vertical integration of patented and proprietary technologies that offer unique skin health benefits.